Besides its effects on the immune components of the tumor stroma, the molecular interplay between Cav1 and cell metabolism has been established [24], with its high expression suppressing c-Myc-induced metabolic reprogramming with an impact on breast stem cancer cells [25]. The gene discussed is MYC; the disease is neoplasm.